Millar JB - Search Results

1

Super-activated interferon-regulatory factors can enhance plasmid immunization.

Bramson JL, Dayball K, Hall JR, Millar JB, Miller M, Wan YH, Lin R, Hiscott J. Bramson JL, et al. Among authors: millar jb. Vaccine. 2003 Mar 28;21(13-14):1363-70. doi: 10.1016/s0264-410x(02)00694-1. Vaccine. 2003. PMID: 12615431

2

Electroporation enables plasmid vaccines to elicit CD8+ T cell responses in the absence of CD4+ T cells.

Dayball K, Millar J, Miller M, Wan YH, Bramson J. Dayball K, et al. J Immunol. 2003 Oct 1;171(7):3379-84. doi: 10.4049/jimmunol.171.7.3379. J Immunol. 2003. PMID: 14500631

3

Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene.

Zhang X, Divangahi M, Ngai P, Santosuosso M, Millar J, Zganiacz A, Wang J, Bramson J, Xing Z. Zhang X, et al. Vaccine. 2007 Jan 26;25(7):1342-52. doi: 10.1016/j.vaccine.2006.09.089. Epub 2006 Oct 10. Vaccine. 2007. PMID: 17052817

4

The magnitude of the CD8+ T cell response produced by recombinant virus vectors is a function of both the antigen and the vector.

Millar J, Dissanayake D, Yang TC, Grinshtein N, Evelegh C, Wan Y, Bramson J. Millar J, et al. Cell Immunol. 2007 Nov-Dec;250(1-2):55-67. doi: 10.1016/j.cellimm.2008.01.005. Epub 2008 Mar 3. Cell Immunol. 2007. PMID: 18313652

5

T-cell immunity generated by recombinant adenovirus vaccines.

Yang TC, Millar JB, Grinshtein N, Bassett J, Finn J, Bramson JL. Yang TC, et al. Among authors: millar jb. Expert Rev Vaccines. 2007 Jun;6(3):347-56. doi: 10.1586/14760584.6.3.347. Expert Rev Vaccines. 2007. PMID: 17542750 Free article. Review.

6

Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus.

Finn JD, Bassett J, Millar JB, Grinshtein N, Yang TC, Parsons R, Evelegh C, Wan Y, Parks RJ, Bramson JL. Finn JD, et al. Among authors: millar jb. J Virol. 2009 Dec;83(23):12027-36. doi: 10.1128/JVI.00593-09. Epub 2009 Sep 16. J Virol. 2009. PMID: 19759135 Free PMC article.

7

Recombinant adenovirus vaccines can successfully elicit CD8+ T cell immunity under conditions of extreme leukopenia.

Grinshtein N, Yang TC, Parsons R, Millar J, Denisova G, Dissanayake D, Leitch J, Wan Y, Bramson J. Grinshtein N, et al. Mol Ther. 2006 Feb;13(2):270-9. doi: 10.1016/j.ymthe.2005.09.018. Epub 2005 Nov 16. Mol Ther. 2006. PMID: 16297666 Free article.

8

The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity.

Yang TC, Millar J, Groves T, Grinshtein N, Parsons R, Takenaka S, Wan Y, Bramson JL. Yang TC, et al. J Immunol. 2006 Jan 1;176(1):200-10. doi: 10.4049/jimmunol.176.1.200. J Immunol. 2006. PMID: 16365411

9

On the role of CD4+ T cells in the CD8+ T-cell response elicited by recombinant adenovirus vaccines.

Yang TC, Millar J, Groves T, Zhou W, Grinshtein N, Parsons R, Evelegh C, Xing Z, Wan Y, Bramson J. Yang TC, et al. Mol Ther. 2007 May;15(5):997-1006. doi: 10.1038/sj.mt.6300130. Epub 2007 Mar 20. Mol Ther. 2007. PMID: 17375073 Free article.

10

High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome.

Grinshtein N, Ventresca M, Margl R, Bernard D, Yang TC, Millar JB, Hummel J, Beermann F, Wan Y, Bramson JL. Grinshtein N, et al. Among authors: millar jb. Cancer Gene Ther. 2009 Apr;16(4):338-50. doi: 10.1038/cgt.2008.89. Epub 2008 Nov 7. Cancer Gene Ther. 2009. PMID: 18989352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters